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Neuromodulation has wide ranging potential applications in replacing impaired neural
function (prosthetics), as a novel form of medical treatment (therapy), and as a tool
for investigating neurons and neural function (research). Voltage and current controlled
electrical neural stimulation (ENS) are methods that have already been widely applied
in both neuroscience and clinical practice for neuroprosthetics. However, there are
numerous alternative methods of stimulating or inhibiting neurons. This paper reviews the
state-of-the-art in ENS as well as alternative neuromodulation techniques—presenting the
operational concepts, technical implementation and limitations—in order to inform system
design choices.
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1. INTRODUCTION
Neuromodulation is already a multi-billion dollar industry and is
expected to double in the near future (Gofeld, 2014). Alone has
seen the launch of the European Human Brain Project and the US
Brain Research through Advancing Innovative Neurotechnologies
(BRAIN) Initiative—massive collaborative projects which look
set to enhance our understanding and create myriad new
opportunities in this space.
Today there are 3 main applications for neuromodulation.
(1) Prosthetics—devices that replace or improve impaired sen-
sory, motor or cognitive neural function—examples already
exist in clinical use such as cochlear implants, and many more
are in active development such as retinal and propriocep-
tive implants (Theogarajan, 2012; Williams and Constandinou,
2013). (2) Therapy—devices to neurally regulate the body’s
organs for medical benefit—possibly enabling control of insulin
release for diabetics or renal salt absorption for people with
hypertension (Stanslaski et al., 2012; Famm et al., 2013). It is
also used for treatment of epilepsy, depression, traumatic brain
injury, Parkinsons disease and obesity (Testerman et al., 2006).
(3) Neuroscience research—investigating the function of neurons
and neural networks in the peripheral and central nervous sys-
tem (PNS and CNS)—enhancing or creating new applications for
neuromodulation (Fenno et al., 2011).
All of these applications employ neuromodulation—
stimulating or blocking the flow of Action Potentials (APs)
through the nervous system. Electrical Neural Stimulation (ENS)
has historically been the main technique for neuromodulation
and has played a crucial role in neuroscience ever since Galvani
first demonstrated that neurons could be electrically stimulated
in the 18th century. However, recent developments in alternative
modulation methods potentially offer significant advantages over
ENS and could catalyze a wide expansion of neuromodulation
for clinical applications.
This paper presents the current state of the art in neuro-
modulationmethods—describing advantages, limitations, imple-
mentations and applicability. It is laid out as follows: section 2
discusses the physics of action potential creation; section 3
describes and contrasts the various methods of achieving
neuromodulation; and section 4 summarizes the current state of
the art.
2. BIOPHYSICS OF ACTION POTENTIAL GENERATION
Neuronal cell membranes consist mainly of a phospholipid
bilayer across which selective ion pumps work to create a sepa-
ration of charge, ultimately resulting in a resting cell membrane
polarization where the intracellular potential is between 60 and
80mV below the extracellular fluid and where the bilayer acts as
the dielectric of a capacitor (Figure 1A).
Neural stimulation works by causing a depolarization of
part of the cell membrane. If this depolarization reduces the
transmembrane potential to a critical level (threshold), volt-
age gated sodium ion channels open and a positive feedback
loop is created that amplifies a small depolarization (∼15mV)
into a full reverse polarization of the membrane (Figure 1B)
and an action potential is created. This in turn depolarizes the
surrounding membrane and ultimately causes the action poten-
tial to propagate along the neuron. The states and dynamics
of voltage gated sodium and potassium channels play major
roles in neuromodulation. Examples of two types of transmem-
brane currents: depolarizing (by convention negative current,
typically sodium ions, INa, or calcium ions) and hyperpolariz-
ing (positive current, typically potassium ions, IK) are shown in
Figure 1B.
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FIGURE 1 | (A) The phospholipid cell membrane, ionic charges and an ion channel. (B) A typical action potential (i) stimulation causing depolarization to above
threshold, (ii) Na+ channels open and Na+ enters cell, (iii) K+ channels are open and K+ leaves cell, (iv) ion pumps restore resting potential.
FIGURE 2 | (A) A cross-section of a myelinated nerve axon stimulated
using an external stimulation electrode and an equivalent circuit model. (B)
An AP generation in the nerve: simulation on the Neuron platform for AP
generation with axon diameter of 15µm, L = 1.5mm, T = 23◦C,
stimulus = 300µs, stimulus current of 147µA. Lines show the extracellular
(Ve) and membrane voltage (Vm = Vi − Ve, Vi is intracellular voltage) at the
nodes 1, 2, and 3 shown in (A). For more details about the
electrode-electrolyte model and the nerve model which is in this case
Xenopus laevis sciatic nerve see Mou et al. (2012).
When the axon is coated in a myelin sheath (as depicted in
Figure 2) the exchange of ions is limited to the gaps in the sheath
(the Nodes of Ranvier). This restriction causes action potential to
appear to leap from node to node, whilst the myelination of the
axon significantly reduces the membrane capacitance and greatly
increasing the speed of the AP propagation.
Each neural cell represents an spatially extended electri-
cally active object and in order to model it the cell can be
considered to be divided into equipotential compartments (as
shown in Figure 2). Then the change of the charge (Q) inside a
compartment is given by:
dQ
dt
= −Iionic + Iintracell + Iinjected (1)
where Iionic represents the currents through the ion channels and
pumps into that compartment, Iintracell is the internal cell current
influx from neighboring compartments, and Iinjected are exter-
nally injected currents. Replacing Q = CmU in Equation (1), it
becomes a classical Hodgkin-Huxley type Equation (Hodgkin
and Huxley, 1952).
Cm
dVm
dt
= −
∑
k
Iion,k +
∑
i
Ga,i(Vext,i − Vext)
+ Iinjected − (Vm + Vrest)dCm
dt
(2)
where Cm and Vm are the membrane capacitance and the reduced
membrane voltage of the considered cell compartment (we drop
any index to label it in order to simplify equations), and Vm =
U − Vrest where Vrest is the resting voltage across the membrane.
Also U = Vint − Vext , where Vint and Vext are the internal and
external electrical potential of a compartment. Ga,i is the conduc-
tance of axoplasm between the compartment i and the considered
compartment. The ionic current of the type k in Equation (2) is
given by:
Iion,k = g¯kξpkηqk(Vm − Ek) (3)
where g¯k is the maximum conductance of the ion channels
relevant for this ionic current, ξ and η are the ion channel acti-
vation and inactivation variables respectively, pk and qk are the
exponents which model these gating mechanisms, and Ek is the
reversal potential of the channel. All activation (ξ) and inactiva-
tion (η) variables can be described by differential equations of the
form:
dξ
dt
= [αk(Vm, t) · (1 − ξ) − βk(Vm, t) · ξ] (4)
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where αk(Vm, t) and βk(Vm, t) are voltage and time-dependent
rate functions. They can also depend on the concentration of
certain ion species (such as Ca2+, for example for calcium depen-
dent potassium ion channels). In the case of optogenetic ion
channels (such as channelrhodopsin, halorhodopsin, etc) they
depend on the light flux as well. Furthermore they can depend on
the concentration of various neurotransmitters in the case when
Equations (3, 4) describe synaptic currents.
Generally speaking both membrane kinetics and the chan-
nel conductance (permeability) are affected by tempera-
ture (Hodgkin and Huxley, 1952; Huxley, 1959). Hence both
Equations (3, 4) may include a thermic coefficient φ, intro-
duced as a multiplier of the expression on the right-hand side of
these equation. The thermic coefficient depends on the difference
between the actual temperature T and a referent temperature T0
and was first introduced by Hodgkin and Huxley (Hodgkin and
Huxley, 1952; Huxley, 1959) to describe the acceleration in the
membrane kinetics. It usually takes the form:
φ = Q(T−T0)/1010 (5)
where Q10 is a special constant corresponding to the kinetics and
permeability increase when the temperature is increased by 10◦C.
Note that the model described by Equation (2) assumes that
the extracellular potential that is produced by the neuron’s own
activity is negligible. Furthermore, it is assumed that the ionic
pumps quickly restore the ionic gradients across the membrane
so that the reversal potentials in Equation (3) are constant (oth-
erwise the Goldman-Hodgkin-Katz equation should be used for
the ionic currents).
3. NEUROMODULATION MODALITIES
Based on Equation (2), a depolarization can be initiated in a
number of ways. This section describes 6 classes of neuromodu-
lation (including the principle of operation and current methods
of implementation) and contrasts key parameters in Table 1.
3.1. DIRECT ELECTRICAL
Direct electrical stimulation uses electrodes to apply a potential
gradient across a neuron (e.g., differing extracellular potentials
at nodes Vext,1, Vext,2, and Vext,3 in Figure 2 (return electrode is
placed in a distant area), which are initially closely followed by the
intracellular potentials) causing intracellular ionic current flow
(Iintracell) and localized depolarization and hyperpolarization of
the cell membrane (Vm1, Vm2, and Vm3 in Figure 2B) that results
in neural stimulation. Applying a different potential gradient can
be used to create a region of cell membrane hyperpolarization
sufficient to block action potential propagation, thereby achiev-
ing neural inhibition. More complex stimulation, inhibition and
selectivity mechanisms are also possible by applying waveforms
that exploit the differing time constants of the ion channels—for
example anode break stimulation occurs when a long hyperpo-
larizing (inhibitory) pulse is suddenly ceased and results from
differences in the rate that the sodium activation and inactivation
gates change state (Zhou and Greenbaum, 2010).
Key considerations for direct electrical stimulation are safety,
energy efficiency, area, spatial resolution and programmability.
Safety is largely determined by two key characteristics: (1) the
electrode material biocompatibility, and (2) minimizing the net
creation of harmful electrochemical products. This latter crite-
ria is typically achieved by limiting the rate and total amount
of charge delivered through the electrodes, restricting the max-
imum potential difference across the electrodes and minimizing
the residual charge left on the electrodes following stimula-
tion. Commercial products use large DC blocking capacitors to
limit this residual charge, improving safety at the expense of
size and weight (which limits the number of channels that can
be implemented). As a result, designs free of blocking capac-
itors are an active area of research (Sit and Sarpeshkar, 2007;
Liu et al., 2008). Electrode size (typical diameters are in the
order of 0.1mm) is important in determining spatial resolu-
tion, however, minimizing the electrodes is not only limited
by fabrication capability but also the required charge to be
delivered and the maximum safe charge that an electrode can
deliver per unit surface area (a function of the electrode sur-
face material). In practice spatial resolution is also limited by
how close the electrode is to the target neural tissue. As this
distance increases the stimulation strength must be increased
in order to remain effective—causing a larger activation vol-
ume and stimulation of other non-target neurons. The time
between stimulation onset and action potential generation (AP
latency) depends on the activation time constant of the volt-
age gated ion channels. It varies with neuron and ionic types
and is typically in the order of milliseconds. There is a trend
in research toward increasing stimulator programmability—
providing control over all the parameters related to the stimulus
waveform—which potentially allows changes to stimulation effi-
cacy without changing stimulator or repositioning the elec-
trodes (Macherey et al., 2006; Wongsarnpigoon and Grill,
2010).
The required potential gradients for stimulation can be gener-
ated using Voltage, Current or Charge controlled stimulators (see
Figure 3).
3.1.1. Voltage controlled
Directly applying a voltage between two electrodes is the simplest
and lowest power method of direct neural stimulation, however,
the lack of control of charge delivered to the electrodes leads
to electrode degradation and toxic redox products. Clinically
these stimulators are used in Deep Brain Stimulation (Hardesty
and Sackeim, 2007) or muscular stimulation [e.g., pacemak-
ers (Wong et al., 2004)] where the low power consumption and
previously demonstrated therapeutic efficacy are the dominant
considerations.
3.1.2. Current controlled
In current controlled stimulation the current flowing between
two electrodes is controlled by applying a time varying poten-
tial difference across the electrodes. Controlling current enables
charge balanced waveforms to be used (e.g., by careful calibra-
tion of current sources, use of an H-bridge; or series DC blocking
capacitors) and the charge delivered to the electrodes can be
constrained within their charge capacity. However, controlling
the current leads to significant power waste with implications
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for tissue damage and battery lifetime. Clinically this approach
is used in cochlear implants and is the most popular method
in research publications (Thurbon et al., 1998; Srinivasan et al.,
2010).
Transcranial Direct Current Stimulation (tDCS) has recently
been used to study the physiology of the CNS in human (Nitsche
and Paulus, 2000). It is a safe, non-invasive method, but with low
spatial resolution (in commonwith other non-invasive methods).
Yet, Horvath et al. (2014) points out that more research is needed
before drawing a useful conclusion on the efficacy and reliability
of tDCS.
3.1.3. Charge controlled
Charge controlled stimulation combines voltage stimulation with
a capacitor to limit or control the charge delivered to the elec-
trodes (Ghovanloo, 2006; Bawa, 2008; Rosellini et al., 2011;
Luan and Constandinou, 2012). In terms of biocompatibility and
power consumption, this approach offers a mid-ground between
current and voltage controlled stimulation, however, it is not yet
been reported to be in clinical use.
3.2. MAGNETIC
The mechanism for magnetic stimulation is similar to that of
direct electrical stimulation, except that the potential gradients
are induced in the tissue by a rapidly changing strong magnetic
field (>1 T)—typically generated by discharging large capacitors
through an electromagnet or via kilowatt amplifier.
It is usually implemented transcutaneously [e.g., Transcranial
Magnetic Stimulation (TMS)] and hence non-invasively. The
removal of the electrochemical issues associated with the elec-
trode, potentially offers a major advantage over electrical stimula-
tion, however, these devices currently offer poor spatial selectivity
and high peak power consumption. The improvement of stimu-
lus focality mainly relies on the redesign of the stimulation coil.
Recently, Bonmassar et al. (2012) reported on the design of a
micro-TMS (µTMS) system which reduces the spatial resolution
by an order of magnitude. However, the large power consumption
is an obstacle for building a fully implantable stimulator.
Hand-held TMS devices have been used for neuroscience
purposes and clinically for stroke and depression treatment.
However, cautions must be paid when using TMS with any metal-
lic implant like pacemaker, where the metal sheet could be heated
by the eddy current generated during TMS. Reviews on TMS can
be found in Rossini et al. (2010) and in combination with tDCS
as two main methods for exploring the dynamics of the human
CNS in Dayan et al. (2013).
FIGURE 3 | (A) Current-Controlled Stimulation (B) Voltage-Controlled
Stimulation (C) Charge-Controlled Stimulation (D) Electrode-Electrolyte
Interface model [Rs is solution spreading resistance, Cdl is double layer
capacitance, Rt is charge transfer resistance (Luan and Constandinou,
2012)]
3.3. OPTOGENETIC
Optogenetics is a relatively new neuromodulation technology in
which light-sensitive proteins (“opsins”) are genetically inserted
into cell membranes or cells (Nagel et al., 2003; Boyden et al.,
2005). These proteins act as light-activated ion pumps, chan-
nels or enzymes to achieve fast and precise optical manipulation
of electrical and biochemical processes in cells as well as mod-
ulation of signaling cascades (Yizhar et al., 2011). Optogenetics
has numerous applications which are only beginning to be
explored—hence its choice as “Method of the Year 2010” by
Nature Methods (Deisseroth, 2011). The first and most famous
of these opsins were channelrhodopsin for neural stimulation
(Nagel et al., 2003) and halorhodopsin for neural inhibition
(Chow et al., 2010) (see Figure 4). Since then a wide range of
opsins with varying temporal, chemical and spectral proper-
ties have been discovered. This has been combined with par-
allel development of techniques for genetic manipulation and
Na
K
H
Ca
Cl
Na
K
H
Ca Cl
ChR2 HR
460nm light 570nm light
A
B
C
1s 2ms
FIGURE 4 | (A) An unilluminated channelrhodopsin-2 (ChR2) ion channel
and halorhodopsin (HR) ion pump are closed and inactive. (B) Once
exposed to light of specific wavelength, ChR2 allows certain positive ions
into the cell, and HR begins to pump chloride ions in. (C) Activation of ChR2
initiates individual action potentials, in contrast HR activation suppresses
action potentials, redrawn from Boyden et al. (2005) and Chow et al. (2010).
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improvements in our understanding of gene expression; ulti-
mately resulting in a tool with peerless precision for neural
manipulation.
However, creating a chronic, portable implant capable of
exploiting even a fraction of the potential of this technique
remains an open challenge (Williams and Denison, 2013). In-
vivo experimental setups to date have typically involved either
benchtop lasers (coupled with fiber-optics) or transcutaneous
illumination. However, McCall et al. (2013) have taken a major
step in demonstrating a fully wireless system of up to 25 chan-
nels albeit with only a fraction of the feasible targeting precision.
The need to genetically modify the neurons is a major draw-
back in applying this technology in humans, both from a safety
and ethics perspective (especially in the brain and CNS in gen-
eral) and in clinical applications in the PNS (where it is unclear
how quickly new ion channels would be expressed along the long
axons that exist in the periphery). On the more technical side a
potential source of noise and uncertainty is that cells are typically
loaded with a vector and then variations of the gene expression
can lead to different responses for the same stimulus. However,
the high precision and ability to selectively express the opsins in
target neuron types makes this a highly attractive tool for neu-
roscience [especially for decoding brain circuitry (Yizhar et al.,
2011)] and for retinal prosthesis development (Busskamp and
Roska, 2011).
3.4. THERMAL
Thermal modulation of neural activity is believed to result from
a combination of the temperature induced changes in the trans-
membrane capacitance (the last term in the RHS of Equation 2)
and non-uniform changes in the conductance dynamics of the
various ionic channels (Equations 3, 4) (Duke et al., 2013;
Peterson and Tyler, 2014).
During rapid localized heating, the capacitive effect dominates
and the reduced transmembrane capacitance leads to ionic cur-
rent flow, depolarization and action potential initiation (Shapiro
et al., 2012; Duke et al., 2013). In this case the last term in
Equation (2) creates a stimulus proportional to the speed of tem-
perature change (dT/dt, because dCm/dt can be expressed as:
dCm/dt = (dCm/dT) · (dT/dt). The plasma membrane electri-
cal capacitance is reversibly affected by the temperature (dCm/dT
term) because the total capacitance of a lipid membrane in elec-
trolyte solution includes in-series capacitance of ionic double
layers at the interface between the (polar) membrane surface and
electrolyte (Shapiro et al., 2012). Conversely during slow heating
the changes to ionic channels dominate and in particular changes
to Na+ and K+ activation/deactivation dynamics prevent action
potential initiation and propagation (Mou et al., 2012; Duke et al.,
2013). Thermal damage to tissue is a major issue with this method
of neuromodulation, especially for suppression due to the higher
temperatures and slower, more diffuse heating necessary (Wells
et al., 2007).
There are a number of ways of inducing this thermal change,
here we cover optical and nanoparticle stimulation. Bench-top
equipment has previously been required, however, an emerging
method using a CMOS lab-on-chip micro-heater array is recently
reported in Reverter et al. (2014).
3.4.1. Optically induced thermal modulation
Rapid heating can be achieved through the targeting of near infra-
red laser light on a neuron or nerve (Wells et al., 2005; Duke
et al., 2013). This enables a typical AP latency of the order of ms
and a high spatial resolution of the order of 10µm. But effec-
tive stimulation and damage thresholds are within an order of
magnitude for some neurons which is potentially a cause for con-
cern (Richter et al., 2011). Laser induced heating has also been
demonstrated for neural inhibition as part of a hybrid electri-
cal stimulation/thermal inhibition device (Mou et al., 2012; Duke
et al., 2013).
3.4.2. Microwave/RF heating of nanoparticles
Magnetic nanoparticles can absorb RF radiation and therefore
heat surrounding tissue. Combining these particles with proteins
known to bind to specific protein targets on neural cell mem-
branes has been shown to enable focused heating of target cells.
Although this approach could potentially give very good spatial
resolution, the temporal resolution and power consumption of
this technique remain poor and the safety of the nanoparticles is
unclear (Huang et al., 2010).
3.5. ACOUSTIC/MECHANICAL
Acoustic modulation is an emerging method. Experiments have
indicated that on-off modulated ultrasound waves can elicit
action potentials from retinal and brain cells (Tufail et al., 2010;
Naor et al., 2012; Menz et al., 2013). However, very little is
understood about how mechanical deformations (typically in the
cell membrane) affect ion channels, membrane capacitances and
neurons—although proposed mechanisms have included cavita-
tion and thermal effects. Despite a lack of clarity on the actual
mechanism, potential applications for non-invasive Deep Brain
Stimulation and retinal prostheses are being investigated.
The main benefit of this method is that it is non-invasive and
is likely to offer better spatial resolution than other non-invasive
techniques—particularly useful for applications like retinal pros-
theses (Menz et al., 2013). The drawbacks of the acoustic method
is that the standing waves could also stimulate unwanted neural
tissue.
3.6. CHEMICAL
Microfluidics can be used to control the chemical environment
around a neuron, potentially changing its transmembrane or
post-synaptic potential and inducing or suppressing action
potential generation. Achieving high temporal or spatial res-
olution with such systems may be challenging—depending
on concentrations required to elicit effects and the dynamics
of the chemical diffusion, breakdown or uptake in the tissue.
However, it is an approach that may be suited to applications
requiring a longer term effect with a wider area of effect, e.g.,
Deep Brain Stimulation. Major challenges with this approach
include safe chemical storage, modulation efficacy and economic
manufacture.
3.6.1. Neurotransmitter modulation
Neurotransmitter molecules released near the synapses between
two neurons, bind to the receptors in the post-synaptic
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cleft—altering the post-synaptic potential or initiating a chemi-
cal change that affects neuronal signal transmission. The selective
sensitivity of neurons to specific neurotransmitters means that
specific types of neurons can potentially be targeted even in a
heterogeneous environment (like the retina) (Theogarajan, 2012).
However, this approach has limited applicability in the PNSwhere
synapses are absent or only present at the terminus of the axon
which is often too diffuse a target for implantation.
3.6.2. Ionic concentration
Sequestration or release of anions or cations near a neuron
disrupts the diffusion and potential gradients across the cell mem-
brane and acts to modulate neural transmission. This can be
used for standalone inhibition or to reduce required stimulation
thresholds in tandem with another stimulation technique (Song
et al., 2011). The use of ions rather than neurotransmitters widens
the applicability of this technique, enabling it to be used in the
PNS but conversely reduces its specificity.
4. DISCUSSION
Choosing a neuromodulation method for clinical application is
guided by 3 main considerations:
1. The safety of a modulation method (including tissue damage,
side effects and ethical considerations) are of primary impor-
tance. All the techniques discussed here have the potential to
cause harm if misapplied, however, optogenetics and nanopar-
ticle based thermal modulation stand out as facing particularly
tough challenges in making the leap to human clinical use, due
to genetic modification and nanoparticle concerns.
2. The efficacy of each modulation method for a particular appli-
cation is dependent on: the required modulatory effect; the
spatial, temporal and cellular resolution; and the biological
characteristics of the modulation site. Precise control of action
potential timing and frequency (typically desired for sensory
and motor prostheses) is suited to electrical or optogenetic
methods (Figure 5 shows how various methods compare in
terms of spatio-temporal resolution); whereas larger scale,
unfocused neural activity suppression or promotion (such as
brain stimulation for tremor, depression or epilepsy) is better
suited to electrical, magnetic, chemical or potentially thermal
nanoparticle methods.
3. The suitability to a specific application use case (e.g., the fre-
quency, duration and range of situations in which modulation
will be applied) is largely dependent on requirements for acute
or chronic use. Short term use in a clinical setting leads to
a strong preference for a non-invasive solution such as tran-
scranial electrical or magnetic modulation or potentially an
acoustic/mechanical solution. On the other hand, long term,
frequent modulation means portability is a priority and inva-
sive solutions become more acceptable—currently favoring
electrical modulation.
There is a good reason why electrical neural stimulation is the
most widely used today. It is the most mature of the stim-
ulation technologies with low AP latency and capable of a
wide range of spatial resolutions that satisfy most applications.
FIGURE 5 | Spatio-temporal resolution of various neuromodulation
methods. The open circle represents non-invasive methods and the black
dots invasive methods.
Microelectronic fabrication can already produce stimulators that
are small, implantable, low power and safe, and research is under-
way to improve the stimulation efficiency, efficacy and to integrate
more channels onto a single chip. However, ENS is not without
its limitations, and these represent an opportunity for competing
methods to prosper.
This review has identified a wide diversity of available neu-
romodulation techniques which, although less mature, each
demonstrate unique strengths and have the potential to supplant
ENS in specific applications. For example, in deep brain stimula-
tion, spread of electrical stimulus has been linked to side-effects
such as depression. A lot of research has been dedicated to design
a new type of electrode which can shift and confine the stimulus
within a certain area, however, pursuing other neuromodula-
tion methods that provide greater spatial resolution or cellular
specificity may be an alternative solution—e.g., chemical modu-
lation using neurotransmitter release (offering a degree of cellular
specificity), or optogenetics (with high spatial resolution and cel-
lular specificity) may one day be viable options. The shift from
ENS is already well underway in non-clinical applications, where
optogenetics is a frequently favored method. Nano-particle based
thermal stimulation and neurotransmitter chemical stimulation
are also alternatives that offer cellular specificity and may find
successful niches in this area.
Looking to the future, we see a trend for multimodal
neuromodulation—combining the advantages and mitigating
the disadvantages of different modalities. Examples include
combining current stimulation with voltage control to reduce
power (Williams and Constandinou, 2013), voltage stimulation
with current control (Luan and Constandinou, 2012), hybrid
electro-optical stimulation (Duke et al., 2012; Mou et al., 2012),
or integrating current controlled stimulation with microfluidics
to reduce stimulation thresholds (Song et al., 2011). Electrical
neural stimulation remains the gold standard in clinical use (espe-
cially for chronic use or in the PNS), however, for applications
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demanding increased efficacy, increased modulation complexity
and reduced side-effects the days of using just electrical stimula-
tion on its own may be numbered.
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